Joseph Hiatt

University of California, San Francisco

H-index: 23

North America-United States

About Joseph Hiatt

Joseph Hiatt, With an exceptional h-index of 23 and a recent h-index of 23 (since 2020), a distinguished researcher at University of California, San Francisco, specializes in the field of Infectious Disease.

His recent articles reflect a diverse array of research interests and contributions to the field:

A functional map of HIV-host interactions in primary human T cells

Evolution of enhanced innate immune evasion by SARS-CoV-2

Host-directed therapies against early-lineage SARS-CoV-2 retain efficacy against B. 1.1. 7 variant

Evolution of enhanced innate immune evasion by the SARS-CoV-2 B. 1.1. 7 UK variant

Efficient generation of isogenic primary human myeloid cells using CRISPR-Cas9 ribonucleoproteins

TCF-1 regulates HIV-specific CD8+ T cell expansion capacity

Relationship between CD4 T cell turnover, cellular differentiation and HIV persistence during ART

A SARS-CoV-2 protein interaction map reveals targets for drug repurposing

Joseph Hiatt Information

University	University of California, San Francisco
Position	___
Citations(all)	8550
Citations(since 2020)	8084
Cited By	3249
hIndex(all)	23
hIndex(since 2020)	23
i10Index(all)	24
i10Index(since 2020)	24
Email	Access Email
University Profile Page	University of California, San Francisco
Google Scholar	View Google Scholar Profile

Joseph Hiatt Skills & Research Interests

Infectious Disease

Top articles of Joseph Hiatt

Title	Journal	Author(s)	Publication Date
A functional map of HIV-host interactions in primary human T cells	Nature communications	Joseph Hiatt Judd F Hultquist Michael J McGregor Mehdi Bouhaddou Ryan T Leenay ...	2022/4/1
Evolution of enhanced innate immune evasion by SARS-CoV-2	Nature	Lucy G Thorne Mehdi Bouhaddou Ann-Kathrin Reuschl Lorena Zuliani-Alvarez Ben Polacco ...	2022/2/17
Host-directed therapies against early-lineage SARS-CoV-2 retain efficacy against B. 1.1. 7 variant	BioRxiv	Ann-Kathrin Reuschl Lucy G Thorne Lorena Zuliani-Alvarez Mehdi Bouhaddou Kirsten Obernier ...	2021/1/24
Evolution of enhanced innate immune evasion by the SARS-CoV-2 B. 1.1. 7 UK variant	BioRxiv	Lucy G Thorne Mehdi Bouhaddou Ann-Kathrin Reuschl Lorena Zuliani-Alvarez Ben Polacco ...	2021/6/7
Efficient generation of isogenic primary human myeloid cells using CRISPR-Cas9 ribonucleoproteins	Cell reports	Joseph Hiatt Devin A Cavero Michael J McGregor Weihao Zheng Jonathan M Budzik ...	2021/5/11
TCF-1 regulates HIV-specific CD8+ T cell expansion capacity	JCI insight	Rachel L Rutishauser Christian Deo T Deguit Joseph Hiatt Franziska Blaeschke Theodore L Roth ...	2021/2/2
Relationship between CD4 T cell turnover, cellular differentiation and HIV persistence during ART	PLoS pathogens	Charline Bacchus-Souffan Mark Fitch Jori Symons Mohamed Abdel-Mohsen Daniel B Reeves ...	2021/1/19
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing	Nature	David E Gordon Gwendolyn M Jang Mehdi Bouhaddou Jiewei Xu Kirsten Obernier ...	2020/7/16
Pooled knockin targeting for genome engineering of cellular immunotherapies	Cell	Theodore L Roth P Jonathan Li Franziska Blaeschke Jasper F Nies Ryan Apathy ...	2020/4/30
Cyclophilin A Prevents HIV-1 Restriction in Lymphocytes by Blocking Human TRIM5α Binding to the viral Core	Cell reports	Anastasia Selyutina Mirjana Persaud Lacy M Simons Angel Bulnes-Ramos Cindy Buffone ...	2020/3/17
Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms	Science	David E Gordon Joseph Hiatt Mehdi Bouhaddou Veronica V Rezelj Svenja Ulferts ...	2020/12/4
Discovery of Host-Directed Antiviral Therapies		Joseph Hiatt	2020
Evaluation of SARS-CoV-2 serology assays reveals a range of test performance	Nature biotechnology	Jeffrey D Whitman Joseph Hiatt Cody T Mowery Brian R Shy Ruby Yu ...	2020/10
The global phosphorylation landscape of SARS-CoV-2 infection	Cell	Mehdi Bouhaddou Danish Memon Bjoern Meyer Kris M White Veronica V Rezelj ...	2020/8/6